Search - tctmd.com

Displaying 1 - 20 of 76

Sort: Relevancy | Date

News Daily News

Top Heart Failure News of 2024

Todd Neale

December 31, 2024

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Daily News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

L.A. McKeown

December 13, 2024

News Daily News

Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT

L.A. McKeown

December 05, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2024

Shelley Wood

December 03, 2024

News Conference News AHA 2024

Novel AI-Based, Noninvasive Sensor Can Accurately Measure PCWP in HFrEF

Yael L. Maxwell

November 25, 2024

News Conference News AHA 2024

REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients

L.A. McKeown

November 22, 2024

News Conference News AHA 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Shelley Wood

November 17, 2024

Presentation AHA 2024

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Presenter: Milton Packer

November 16, 2024

News Conference News AHA 2024

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Michael O'Riordan

November 16, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Features

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

Todd Neale

November 13, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

Presentation TCT 2024

TCT 468: No-Implant Interatrial Shunt for Heart Failure With Preserved and Mildly-Reduced Ejection Fraction: Twelve-Month Outcomes From Multi-Center Pilot Feasibility Studies

Presenter: Brian Potter

October 28, 2024

News Opinion CV Team Dispatch

October 2024 Dispatch for the CV Team

L.A. McKeown

October 25, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

L.A. McKeown

October 11, 2024

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

L.A. McKeown

October 04, 2024

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

L.A. McKeown

October 02, 2024

Advertisement

Top Heart Failure News of 2024

December 2024 Dispatch for the CV Team

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT

TCTMD’s Top 10 Most Popular Stories for November 2024

Novel AI-Based, Noninvasive Sensor Can Accurately Measure PCWP in HFrEF

REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

TCT 468: No-Implant Interatrial Shunt for Heart Failure With Preserved and Mildly-Reduced Ejection Fraction: Twelve-Month Outcomes From Multi-Center Pilot Feasibility Studies

October 2024 Dispatch for the CV Team

What’s Going to Be Big at TCT 2024?

AHA Statement Outlines Cardiac Contributions to Brain Health

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content